Please login to the form below

Not currently logged in


This page shows the latest Arcoxia news and features for those working in and with pharma, biotech and healthcare.

Grunenthal to market MSD’s pain drug

Grunenthal to market MSD’s pain drug

In these countries, Grünenthal will hold exclusive promotion and distribution rights to the COX-2 inhibitor etoricoxib under the brand name Arcoxia. ... During this time Arcoxia has made a substantial amount of money for MSD - known as Merck &Co in the

Latest news

  • Icon Icon

    Hotfoot from seeing Madonna at the New York Superbowl, Stephanie Berman gives us some inspired thoughts on the power of branding - PMLiVE

  • New Accounts, April, 2009 - Advertising

    MSD  . Arcoxia . Arthritis . RFA Advertising . NAPP . New product . Oncology . RFA Advertising .

  • New Accounts, March, 2009 - Advertising

    MSD  . Arcoxia . Arthritis . RFA Advertising . NAPP  . Depocyte . Oncology. RFA Advertising .

  • New Accounts, February, 2009 - Advertising

    Merck Serono  . N/A . Corporate . Life Healthcare Communications  . MSD/ Schering-Plough  . Ezetrol . Cardiology . RFA Advertising . MSD. Singulair . Asthma . RFA Advertising . MSD  . Arcoxia . Arthritis . RFA Advertising . NAPP  .

  • Merck lambasted over semi-revelation

    Merck claimed that the product is the most widely prescribed traditional NSAID in the world', and hence was an appropriate comparator for Arcoxia. ... Also, people withdrawing due to oedema-related adverse effects was significantly higher than in

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....